Figure 3. Knockdown of CASC9 reverses chemoresistance in BGC823/DR and SGC7901/DR cells.
(A) IC50 of BGC823/DR and SGC7901/DR cells to paclitaxel after CASC9 knockdown. (B) IC50 of BGC823/DR and SGC7901/DR cells to adriamycin after CASC9 knockdown. (C) The expression of MDR1 protein in BGC823/DR and SGC7901/DR cells after CASC9 knockdown.